citalopram has been researched along with glycine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Layer, RT; Nowak, G; Paul, IA; Popik, P; Skolnick, P | 1 |
| Li, Y; Nowak, G; Paul, IA | 1 |
| Legutko, B; Nowak, G; Popik, P; Skolnick, P | 1 |
| Biernacka, J; Drews, M; Fiehn, O; Hebbring, S; Jenkins, GD; Ji, Y; Kaddurah-Daouk, R; Mrazek, DA; Schaid, D; Snyder, K; Weinshilboum, RM; Zeng, Z; Zhu, H | 1 |
| Abo, R; Batzler, A; Biernacka, J; Drews, M; Fiehn, O; Fridley, B; Hebbring, S; Jenkins, GD; Ji, Y; Kaddurah-Daouk, R; Kamatani, N; Kubo, M; Mrazek, DA; Mushiroda, T; Nakamura, Y; Schaid, D; Snyder, K; Weinshilboum, RM; Zeng, ZB; Zhu, H | 1 |
1 trial(s) available for citalopram and glycine
| Article | Year |
|---|---|
Glycine and a glycine dehydrogenase (GLDC) SNP as citalopram/escitalopram response biomarkers in depression: pharmacometabolomics-informed pharmacogenomics.
Topics: Biomarkers, Pharmacological; Cell Line; Chromosomes, Human, Pair 9; Citalopram; Depressive Disorder, Major; DNA-Binding Proteins; Drug Monitoring; Female; Genetic Association Studies; Glycine; Glycine Dehydrogenase (Decarboxylating); Humans; Introns; Linkage Disequilibrium; Male; Metabolome; Nuclear Proteins; Polymorphism, Single Nucleotide; Selective Serotonin Reuptake Inhibitors | 2011 |
7 other study(ies) available for citalopram and glycine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments.
Topics: Adaptation, Physiological; Animals; Antidepressive Agents; Citalopram; Dose-Response Relationship, Drug; Electroshock; Glycine; Imipramine; Kynurenic Acid; Male; Mice; Receptors, N-Methyl-D-Aspartate; Sensitivity and Specificity; Strychnine; Time Factors; Tritium | 1994 |
Adaptation of cortical but not hippocampal NMDA receptors after chronic citalopram treatment.
Topics: Adaptation, Physiological; Animals; Binding, Competitive; Cerebral Cortex; Citalopram; Dose-Response Relationship, Drug; Glycine; Hippocampus; Male; Mice; Receptors, N-Methyl-D-Aspartate | 1996 |
Adaptation of cortical NMDA receptors by chronic treatment with specific serotonin reuptake inhibitors.
Topics: 2-Amino-5-phosphonovalerate; Adaptation, Physiological; Animals; Binding, Competitive; Cerebral Cortex; Citalopram; Excitatory Amino Acid Antagonists; Fluoxetine; Glycine; Male; Mice; Radioligand Assay; Receptors, N-Methyl-D-Aspartate; Selective Serotonin Reuptake Inhibitors | 1998 |
Merging pharmacometabolomics with pharmacogenomics using '1000 Genomes' single-nucleotide polymorphism imputation: selective serotonin reuptake inhibitor response pharmacogenomics.
Topics: Citalopram; Depressive Disorder; Genome-Wide Association Study; Glycine; Glycine Dehydrogenase; Haplotypes; HapMap Project; Humans; Metabolic Networks and Pathways; Metabolomics; Pharmacogenetics; Polymorphism, Single Nucleotide; Selective Serotonin Reuptake Inhibitors | 2012 |